The administration of four-factor prothrombin complex concentrate exacerbates thrombin generation in trauma patients at risk of massive transfusion: an ancillary study of the PROCOAG trial

被引：0
|
作者：
Jules Greze
Raphael Marlu
Mariette Baud
Landry Seyve
Tobias Gauss
Pierre Bouzat
机构：
[1] Univ. Grenoble Alpes,Inserm, U1216, CHU Grenoble Alpes, Grenoble Institute Neurosciences
[2] Univ. Grenoble Alpes,CNRS UMR5525 TIMC, Hemostasis Laboratory, CHU Grenoble Alpes
[3] CHU Grenoble Alpes,Hemostasis Laboratory
[4] Pôle d’Anesthésie-Réanimation,undefined
[5] Hôpital Albert Michallon,undefined
来源：
Critical Care | / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Evaluation of fixed dose four-factor prothrombin complex concentrate for warfarin reversal at a level 1 trauma center
    H Drone
    J Jancik
    J Gorlin
    M McCarthy
    Critical Care, 19 (Suppl 1):
  • [32] Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage
    Pathan, Sophia
    HOSPITAL PHARMACY, 2024, 59 (04) : 394 - 406
  • [33] Air Ambulance Delivery and Administration of Four-factor Prothrombin Complex Concentrate Is Feasible and Decreases Time to Anticoagulation Reversal
    Vines, Claire
    Tesseneer, Stephanie J.
    Cox, Robert D.
    Darsey, Damon A.
    Carbrey, Kristin
    Puskarich, Michael A.
    ACADEMIC EMERGENCY MEDICINE, 2018, 25 (01) : 33 - 40
  • [34] Administration of four-factor prothrombin complex concentrate for a life-threatening bleed in a Jehovah's Witness patient
    Cole, Jennifer L.
    McLeod, Nathanael D.
    BLOOD COAGULATION & FIBRINOLYSIS, 2018, 29 (01) : 120 - 122
  • [35] Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors
    Grottke, Oliver
    Schulman, Sam
    ANESTHESIOLOGY, 2019, 131 (05) : 1153 - 1165
  • [36] Time to four-factor prothrombin complex concentrate administration decreased by presence of a 24/7 pharmacist in the emergency department
    Kozlow, Erin A.
    Livings, Sarah E.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (01): : 33 - 39
  • [37] Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding
    Quinlan, Daniel J.
    Eikelboom, John W.
    Weitz, Jeffrey I.
    CIRCULATION, 2013, 128 (11) : 1179 - 1181
  • [38] The Off-Label Use of Four-Factor Prothrombin Complex Concentrate: A Single Institution Retrospective Study
    Scharman, Carlton D.
    Kim, Edward
    Shatzel, Joseph J.
    Deloughery, Thomas G.
    BLOOD, 2017, 130
  • [39] Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage
    Cicci, Corey D.
    Weiss, Ashley
    Dang, Cathyyen
    Stanton, Matthew
    Feldman, Ryan
    PHARMACOTHERAPY, 2022, 42 (05): : 366 - 374
  • [40] Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study
    Estroff, Jordan M.
    Devlin, Joseph
    Hoteit, Lara
    Hassoune, Adnan
    Neal, Matthew D.
    Brown, Joshua B.
    Lu, Liling
    Kotch, Shannon
    Hazelton, Joshua P.
    Christian, Ashton B.
    Yeates, Eric O.
    Nahmias, Jeffry
    Jacobson, Lewis E.
    Williams, Jamie
    Schuster, Kevin M.
    O'Connor, Rick
    Semon, Gregory R.
    Straughn, Angela D.
    Cullinane, Daniel
    Egodage, Tanya
    Kincaid, Michelle
    Rollins, Allison
    Amdur, Richard
    Sarani, Babak
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2024, 97 (04): : 541 - 545
12345